Targeted metabolomics in colorectal cancer: a strategic approach using standardized laboratory tests of the blood and urine

References

• Brahimi-Horn MC, Chiche J, Pouyssegur J. Hypoxia signalling controls metabolic demand. Curr Opin Cell Biol. 2007;19(2):223–229.
   PubMed Web of Science ®Google Scholar
• Harris AL. Hypoxia -- a key regulatory factor in tumour growth. Nat Rev Cancer. 2002;2(1):38–47.
   PubMed Web of Science ®Google Scholar
• De Jaeger K, Kavanagh MC, Hill RP. Relationship of hypoxia to metastatic ability in rodent tumours. Br J Cancer. 2001;84(9):1280–1285.
   PubMed Web of Science ®Google Scholar
• Semenza G. Tumor metabolism: cancer cells give and take lactate. J Clin Invest. 2008;118(12):3835–3837.
   PubMed Web of Science ®Google Scholar
• Munoz-Pinedo C, El Mjiyad N, Ricci JE. Cancer metabolism: current perspectives and future directions. Cell Death Dis. 2012;3:e248.
   PubMed Web of Science ®Google Scholar
• Qiu Y, Cai G, Zhou B, et al. A distinct metabolic signature of human colorectal cancer with prognostic potential. Clin Cancer Res. 2014;20(8):2136–2146.
   PubMed Web of Science ®Google Scholar
• Zhu J, Djukovic D, Deng L, et al. Colorectal cancer detection using targeted serum metabolic profiling. J Proteome Res. 2014;13(9):4120–4130.
   PubMed Web of Science ®Google Scholar
• Denkert C, Budczies J, Weichert W, et al. Metabolite profiling of human colon carcinoma-deregulation of TCA cycle and amino acid turnover. Mol Cancer. 2008;7:72.
   PubMed Web of Science ®Google Scholar
• Hirayama A, Kami K, Sugimoto M, et al. Quantitative metabolome profiling of colon and stomach cancer microenvironment by capillary electrophoresis time-of-flight mass spectrometry. Cancer Res. 2009;69(11):4918–4925.
   PubMed Web of Science ®Google Scholar
• Cheng Y, Xie G, Chen T, et al. Distinct urinary metabolic profile of human colorectal cancer. J Proteome Res. 2012;11(2):1354–1363.
   PubMed Web of Science ®Google Scholar
• Farshidfar F, Weljie AM, Kopciuk KA, et al. A validated metabolomic signature for colorectal cancer: exploration of the clinical value of metabolomics. Br J Cancer. 2016;115(7):848–857.
   PubMed Web of Science ®Google Scholar
• Goveia J, Pircher A, Conradi LC, et al. Meta-analysis of clinical metabolic profiling studies in cancer: challenges and opportunities. EMBO Mol Med. 2016;8(10):1134–1142.
   PubMed Web of Science ®Google Scholar
• Antonowicz S, Kumar S, Wiggins T, Markar SR, Hanna GB. Diagnostic metabolomic blood tests for endoluminal gastrointestinal cancer-a systematic review and assessment of quality. Cancer Epidemiol Biomarkers Prev. 2016;25(1):6–15.
   PubMed Web of Science ®Google Scholar
• de Boer NK, de Meij TG, Oort FA, et al. The scent of colorectal cancer: detection by volatile organic compound analysis. Clin Gastroenterol Hepatol. 2014;12(7):1085–1089.
   PubMed Web of Science ®Google Scholar
• Tan B, Qiu Y, Zou X, et al. Metabonomics identifies serum metabolite markers of colorectal cancer. J Proteome Res. 2013;12(6):3000–3009.
   PubMed Web of Science ®Google Scholar
• Gray LR, Tompkins SC, Taylor EB. Regulation of pyruvate metabolism and human disease. Cell Mol Life Sci. 2014;71(13):2577–2604.
   PubMedGoogle Scholar
• Kraut JA, Madias NE. Metabolic acidosis: pathophysiology, diagnosis and management. Nat Rev Nephrol. 2010;6(5):274–285.
   PubMed Web of Science ®Google Scholar
• Pouyssegur J, Dayan F, Mazure NM. Hypoxia signalling in cancer and approaches to enforce tumour regression. Nature. 2006;441(7092):437–443.
   PubMed Web of Science ®Google Scholar
• Gullino PM, Grantham FH, Smith SH, Haggerty AC. Modifications of the acid-base status of the internal milieu of tumors. J Natl Cancer Inst. 1965;34(6):857–869.
   PubMedGoogle Scholar
• Rademakers SE, Lok J, van der Kogel AJ, Bussink J, Kaanders JH. Metabolic markers in relation to hypoxia; staining patterns and colocalization of pimonidazole, HIF-1alpha, CAIX, LDH-5, GLUT-1, MCT1 and MCT4. BMC Cancer. 2011;11:167.
   PubMed Web of Science ®Google Scholar
• Sun X, Niu G, Chan N, Shen B, Chen X. Tumor hypoxia imaging. Mol Imaging Biol. 2011;13(3):399–410.
   PubMed Web of Science ®Google Scholar
• Qiu Y, Cai G, Su M, et al. Urinary metabonomic study on colorectal cancer. J Proteome Res. 2010;9(3):1627–1634.
   PubMed Web of Science ®Google Scholar
• Nishiumi S, Kobayashi T, Ikeda A, et al. A novel serum metabolomics-based diagnostic approach for colorectal cancer. PLoS One. 2012;7(7):e40459.
   PubMed Web of Science ®Google Scholar